Pattern Bioscience: Funding, Investors & Team (Oct 2026)
Pattern Bioscience, established in 2016, is a private company focused on solving the issue of antibiotic resistance through innovative in vitro diagnostics. The company is creating an advanced clinical microbiology platform using patented phenotypic single-cell technology to quickly identify pathogens and their antibiotic reactions without the typical lengthy culture process. Pattern's Digital CultureTM technology utilizes functional endpoints to cover all resistance mechanisms, leading to more accurate and thorough diagnoses compared to rapid genotypic tests. This platform aims to provide faster and more reliable diagnoses than the current standard of care.
Pattern Bioscience has raised $96.4M across 3 funding rounds on record, the most recent an undisclosed round of $44.2M announced in Aug 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Pattern Bioscience Company Profile and Key Stats
Latest funding round on record: Aug 2025.
Pattern Bioscience Funding Rounds
Pattern Bioscience raised $23.5M in an undisclosed round announced in Jan 2023.
3 months later, a Series C of $28.7M was announced in Apr 2023.
2.3 years later, an undisclosed round of $44.2M was announced in Aug 2025.
Pattern Bioscience Founders and Leadership Team
Contact details for the Pattern Bioscience team: 1 of 1 has an email address on file.
Start 14-day free trial →Pattern Bioscience Funding Compared to Other Biotechnology Startups
Pattern Bioscience's latest round of $44.2M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pattern Bioscience in Biotechnology and Austin
Companies Similar to Pattern Bioscience
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Pattern Bioscience Funding FAQs
What does Pattern Bioscience do?
Pattern Bioscience, established in 2016, is a private company focused on solving the issue of antibiotic resistance through innovative in vitro diagnostics. The company is creating an advanced clinical microbiology platform using patented phenotypic single-cell technology to quickly identify pathogens and their antibiotic reactions without the typical lengthy culture process. Pattern's Digital CultureTM technology utilizes functional endpoints to cover all resistance mechanisms, leading to more accurate and thorough diagnoses compared to rapid genotypic tests. This platform aims to provide faster and more reliable diagnoses than the current standard of care.
How much funding has Pattern Bioscience raised?
Pattern Bioscience has raised $96.4M across 3 rounds on record. The most recent is an undisclosed round of $44.2M announced in Aug 2025.
When did Pattern Bioscience last raise funding?
Pattern Bioscience's most recent funding round on record is an undisclosed round of $44.2M, announced in Aug 2025.
Who is the CEO of Pattern Bioscience?
Nicolas Arab is listed as CEO at Pattern Bioscience.
Where is Pattern Bioscience headquartered?
Pattern Bioscience is based in Austin, Texas, United States.
How many employees does Pattern Bioscience have?
Pattern Bioscience is in the 51-100 employee band.
How does Pattern Bioscience's funding compare to other Biotechnology startups?
Pattern Bioscience's latest round of $44.2M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Pattern Bioscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pattern Bioscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.